Cargando…

Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae

INTRODUCTION AND BACKGROUND: Rapid molecular diagnostics to predict carbapenem resistance well before the availability of routine drug sensitivity testing (DST) can serve as an antimicrobial stewardship tool in the context of high rates of Carbapenem-resistant Enterobacteriaceae (CRE). MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajendran, Surendran, Gopalakrishnan, Ram, Tarigopula, Anil, Kumar, D Suresh, Nambi, P Senthur, Sethuraman, Nandini, Chandran, Chitra, Ramakrishnan, Nagarajan, Ramasubramanian, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504648/
https://www.ncbi.nlm.nih.gov/pubmed/37719341
http://dx.doi.org/10.5005/jp-journals-10071-24533
_version_ 1785106771102138368
author Rajendran, Surendran
Gopalakrishnan, Ram
Tarigopula, Anil
Kumar, D Suresh
Nambi, P Senthur
Sethuraman, Nandini
Chandran, Chitra
Ramakrishnan, Nagarajan
Ramasubramanian, V
author_facet Rajendran, Surendran
Gopalakrishnan, Ram
Tarigopula, Anil
Kumar, D Suresh
Nambi, P Senthur
Sethuraman, Nandini
Chandran, Chitra
Ramakrishnan, Nagarajan
Ramasubramanian, V
author_sort Rajendran, Surendran
collection PubMed
description INTRODUCTION AND BACKGROUND: Rapid molecular diagnostics to predict carbapenem resistance well before the availability of routine drug sensitivity testing (DST) can serve as an antimicrobial stewardship tool in the context of high rates of Carbapenem-resistant Enterobacteriaceae (CRE). MATERIALS AND METHODS: A retrospective observational study of patients more than 18 years of age on whom Xpert Carba-R (FDA approved for rectal swab specimen) was done on gram-negative bacteria (GNB) flagged blood culture samples, in an Indian intensive care unit between January 2015 and November 2018. We analyzed the performance of Xpert Carba-R in comparison with routine DST. RESULTS: A total of 164 GNBs were isolated from 160 patients. Klebsiella pneumoniae and Escherichia coli were the predominant isolates. Carba-R was positive in 35.36% of samples and 45.34% were carbapenem-resistant (CR) on routine DST. The distribution of the CR gene was: Oxacillinase (OXA) (50%), NDM (32.7%) followed by OXA and NDM co-expression (15.51%). The sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, positive predictive value, and negative predictive value of Carba-R were 90.74, 93.15, 13.25, 0.10, 83.58 and 96.31% for Enterobacteriaceae. The median time to obtain the Carba-R report was 30 hours 34 minutes vs 74 hours and 20 minutes for routine DST. Based on the Carba-R report, 9.72% of patients had escalation and 27.08% had de-escalation of antibiotics. CONCLUSION: Xpert Carba-R serves as a rapid diagnostic tool for predicting carbapenem resistance in intensive care unit patients with bacteremia caused by Enterobacteriaceae. HOW TO CITE THIS ARTICLE: Rajendran S, Gopalakrishnan R, Tarigopula A, Kumar DS, Nambi PS, Sethuraman N, et al. Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae. Indian J Crit Care Med 2023;27(9):655–662.
format Online
Article
Text
id pubmed-10504648
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-105046482023-09-17 Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae Rajendran, Surendran Gopalakrishnan, Ram Tarigopula, Anil Kumar, D Suresh Nambi, P Senthur Sethuraman, Nandini Chandran, Chitra Ramakrishnan, Nagarajan Ramasubramanian, V Indian J Crit Care Med Original Article INTRODUCTION AND BACKGROUND: Rapid molecular diagnostics to predict carbapenem resistance well before the availability of routine drug sensitivity testing (DST) can serve as an antimicrobial stewardship tool in the context of high rates of Carbapenem-resistant Enterobacteriaceae (CRE). MATERIALS AND METHODS: A retrospective observational study of patients more than 18 years of age on whom Xpert Carba-R (FDA approved for rectal swab specimen) was done on gram-negative bacteria (GNB) flagged blood culture samples, in an Indian intensive care unit between January 2015 and November 2018. We analyzed the performance of Xpert Carba-R in comparison with routine DST. RESULTS: A total of 164 GNBs were isolated from 160 patients. Klebsiella pneumoniae and Escherichia coli were the predominant isolates. Carba-R was positive in 35.36% of samples and 45.34% were carbapenem-resistant (CR) on routine DST. The distribution of the CR gene was: Oxacillinase (OXA) (50%), NDM (32.7%) followed by OXA and NDM co-expression (15.51%). The sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, positive predictive value, and negative predictive value of Carba-R were 90.74, 93.15, 13.25, 0.10, 83.58 and 96.31% for Enterobacteriaceae. The median time to obtain the Carba-R report was 30 hours 34 minutes vs 74 hours and 20 minutes for routine DST. Based on the Carba-R report, 9.72% of patients had escalation and 27.08% had de-escalation of antibiotics. CONCLUSION: Xpert Carba-R serves as a rapid diagnostic tool for predicting carbapenem resistance in intensive care unit patients with bacteremia caused by Enterobacteriaceae. HOW TO CITE THIS ARTICLE: Rajendran S, Gopalakrishnan R, Tarigopula A, Kumar DS, Nambi PS, Sethuraman N, et al. Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae. Indian J Crit Care Med 2023;27(9):655–662. Jaypee Brothers Medical Publishers 2023-09 /pmc/articles/PMC10504648/ /pubmed/37719341 http://dx.doi.org/10.5005/jp-journals-10071-24533 Text en Copyright © 2023; The Author(s). https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2023 Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Article
Rajendran, Surendran
Gopalakrishnan, Ram
Tarigopula, Anil
Kumar, D Suresh
Nambi, P Senthur
Sethuraman, Nandini
Chandran, Chitra
Ramakrishnan, Nagarajan
Ramasubramanian, V
Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae
title Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae
title_full Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae
title_fullStr Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae
title_full_unstemmed Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae
title_short Xpert Carba-R Assay on Flagged Blood Culture Samples: Clinical Utility in Intensive Care Unit Patients with Bacteremia Caused by Enterobacteriaceae
title_sort xpert carba-r assay on flagged blood culture samples: clinical utility in intensive care unit patients with bacteremia caused by enterobacteriaceae
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504648/
https://www.ncbi.nlm.nih.gov/pubmed/37719341
http://dx.doi.org/10.5005/jp-journals-10071-24533
work_keys_str_mv AT rajendransurendran xpertcarbarassayonflaggedbloodculturesamplesclinicalutilityinintensivecareunitpatientswithbacteremiacausedbyenterobacteriaceae
AT gopalakrishnanram xpertcarbarassayonflaggedbloodculturesamplesclinicalutilityinintensivecareunitpatientswithbacteremiacausedbyenterobacteriaceae
AT tarigopulaanil xpertcarbarassayonflaggedbloodculturesamplesclinicalutilityinintensivecareunitpatientswithbacteremiacausedbyenterobacteriaceae
AT kumardsuresh xpertcarbarassayonflaggedbloodculturesamplesclinicalutilityinintensivecareunitpatientswithbacteremiacausedbyenterobacteriaceae
AT nambipsenthur xpertcarbarassayonflaggedbloodculturesamplesclinicalutilityinintensivecareunitpatientswithbacteremiacausedbyenterobacteriaceae
AT sethuramannandini xpertcarbarassayonflaggedbloodculturesamplesclinicalutilityinintensivecareunitpatientswithbacteremiacausedbyenterobacteriaceae
AT chandranchitra xpertcarbarassayonflaggedbloodculturesamplesclinicalutilityinintensivecareunitpatientswithbacteremiacausedbyenterobacteriaceae
AT ramakrishnannagarajan xpertcarbarassayonflaggedbloodculturesamplesclinicalutilityinintensivecareunitpatientswithbacteremiacausedbyenterobacteriaceae
AT ramasubramanianv xpertcarbarassayonflaggedbloodculturesamplesclinicalutilityinintensivecareunitpatientswithbacteremiacausedbyenterobacteriaceae